{"id":"https://openalex.org/W950863716","doi":"https://doi.org/10.3233/hab-1991-2105","title":"Effect of production method on the systemic clearance rate of a human monoclonal antibody in the rat","display_name":"Effect of production method on the systemic clearance rate of a human monoclonal antibody in the rat","publication_year":1991,"publication_date":"1991-03-01","ids":{"openalex":"https://openalex.org/W950863716","doi":"https://doi.org/10.3233/hab-1991-2105","mag":"950863716","pmid":"https://pubmed.ncbi.nlm.nih.gov/1873495"},"language":"en","primary_location":{"id":"doi:10.3233/hab-1991-2105","doi":"https://doi.org/10.3233/hab-1991-2105","is_oa":false,"landing_page_url":"https://doi.org/10.3233/hab-1991-2105","pdf_url":null,"source":{"id":"https://openalex.org/S2764542884","display_name":"Human Antibodies","issn_l":"0956-960X","issn":["0956-960X","1093-2607","1875-869X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Antibodies","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016128720","display_name":"Stacey S. Gauny","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stacey S. Gauny","raw_affiliation_strings":["Departments of Pharmacology and Process and Product Development, Cetus Corporation, Emeryville, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology and Process and Product Development, Cetus Corporation, Emeryville, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000961644","display_name":"James D. Andya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Andya","raw_affiliation_strings":["Departments of Pharmacology and Process and Product Development, Cetus Corporation, Emeryville, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology and Process and Product Development, Cetus Corporation, Emeryville, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"James Thomson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Thomson","raw_affiliation_strings":["Departments of Pharmacology and Process and Product Development, Cetus Corporation, Emeryville, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology and Process and Product Development, Cetus Corporation, Emeryville, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"John D. Young","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John D. Young","raw_affiliation_strings":["Departments of Pharmacology and Process and Product Development, Cetus Corporation, Emeryville, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology and Process and Product Development, Cetus Corporation, Emeryville, CA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112335068","display_name":"Jeffrey L. Winkelhake","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey L. Winkelhake","raw_affiliation_strings":["Departments of Pharmacology and Process and Product Development, Cetus Corporation, Emeryville, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology and Process and Product Development, Cetus Corporation, Emeryville, CA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.6386,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.64940484,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2","issue":"1","first_page":"33","last_page":"38"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/human-monoclonal-antibodies","display_name":"human monoclonal antibodies","score":0.9520000219345093},{"id":"https://openalex.org/keywords/igm","display_name":"IgM","score":0.5320000052452087},{"id":"https://openalex.org/keywords/circulatory-half-life","display_name":"circulatory half-life","score":0.9480000138282776},{"id":"https://openalex.org/keywords/manufacturing-processes","display_name":"production process","score":0.7210000157356262},{"id":"https://openalex.org/keywords/mouse-ascites","display_name":"mouse ascites","score":0.6520000100135803},{"id":"https://openalex.org/keywords/serum-free-defined-medium","display_name":"serum-free defined medium","score":0.878000020980835},{"id":"https://openalex.org/keywords/endotoxin","display_name":"endotoxin","score":0.6169999837875366},{"id":"https://openalex.org/keywords/gram-negative-bacteria","display_name":"Gram-negative bacteria","score":0.9340000152587891},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7129999995231628}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7305450439453125},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6199095249176025},{"id":"https://openalex.org/C72859922","wikidata":"https://www.wikidata.org/wiki/Q11068","display_name":"Circulatory system","level":2,"score":0.5579746961593628},{"id":"https://openalex.org/C3941253","wikidata":"https://www.wikidata.org/wiki/Q47270","display_name":"Half-life","level":3,"score":0.4119178056716919},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3978966176509857},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35378527641296387},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3349315822124481},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.3226831555366516},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2868430018424988},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.21224111318588257}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007075","descriptor_name":"Immunoglobulin M","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3233/hab-1991-2105","doi":"https://doi.org/10.3233/hab-1991-2105","is_oa":false,"landing_page_url":"https://doi.org/10.3233/hab-1991-2105","pdf_url":null,"source":{"id":"https://openalex.org/S2764542884","display_name":"Human Antibodies","issn_l":"0956-960X","issn":["0956-960X","1093-2607","1875-869X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Antibodies","raw_type":"journal-article"},{"id":"pmid:1873495","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1873495","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human antibodies and hybridomas","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1487020397","https://openalex.org/W1520544265","https://openalex.org/W1530277278","https://openalex.org/W1545979795","https://openalex.org/W1659410498","https://openalex.org/W2001492755","https://openalex.org/W2011888853","https://openalex.org/W2041140334","https://openalex.org/W2057144272","https://openalex.org/W2070422360","https://openalex.org/W2083468403","https://openalex.org/W2089780341","https://openalex.org/W2094945468","https://openalex.org/W2131546616","https://openalex.org/W2167477934","https://openalex.org/W2305627972","https://openalex.org/W2491374885"],"related_works":["https://openalex.org/W410744402","https://openalex.org/W2013125701","https://openalex.org/W2055392120","https://openalex.org/W122720258","https://openalex.org/W2010538029","https://openalex.org/W1587583912","https://openalex.org/W8355184","https://openalex.org/W207465502","https://openalex.org/W1944996883","https://openalex.org/W2070556216"],"abstract_inverted_index":{"Pharmacologic":[0],"studies":[1],"of":[2,35,43,47,51,95,116,118,137,144,159,167,173,193],"human":[3,28,52],"immunoglobulins":[4],"(IgM)":[5],"in":[6,80,92,104,129,151,189],"non-primate":[7],"animal":[8],"models,":[9],"whether":[10],"directed":[11],"toward":[12],"efficacy":[13],"or":[14],"toxicity,":[15],"rely":[16],"on":[17,123],"pharmacokinetic":[18],"parameters":[19],"to":[20],"achieve":[21],"optimal":[22],"doses":[23],"and":[24,38,60,98,140,162],"schedules.":[25],"In":[26],"rodents,":[27],"IgMs":[29],"have":[30],"an":[31,63,141,163],"effective":[32,142,165],"circulatory":[33,78,89,191],"half-life":[34,90,143,166,176,192],"11":[36],"h":[37],"a":[39,48,75,96,134,155],"plasma":[40],"clearance":[41,135,157],"rate":[42,136,158],"0.044":[44],"ml/min/kg.":[45],"Studies":[46],"new":[49],"group":[50],"monoclonal":[53],"antibodies":[54],"(hMAb)":[55],"specific":[56],"for":[57,86,101],"Gram-negative":[58],"bacteria":[59],"endotoxin":[61],"revealed":[62],"IgM":[64],"molecule,":[65],"hMAb-10058,":[66],"which,":[67],"when":[68],"purified":[69],"from":[70],"tissue":[71],"culture":[72],"medium,":[73],"exhibited":[74],"suprisingly":[76],"short":[77,88],"lifetime":[79],"rodents.":[81],"Investigations":[82],"into":[83],"possible":[84],"explanations":[85],"this":[87,194],"resulted":[91],"the":[93,105,147,174,181,190],"development":[94],"simple":[97],"efficient":[99],"method":[100,115],"producing":[102],"hMAbs":[103],"immunodeficient":[106],"NIH-3":[107],"mouse":[108,152],"(bg":[109],"x":[110,112],"nu":[111],"XID).":[113],"This":[114,170],"production":[117],"hMAb-10058":[119,127,149],"had":[120,133,154],"dramatic":[121],"effects":[122],"its":[124],"half-life.":[125],"Whereas":[126],"produced":[128],"serum-free,":[130],"defined":[131],"medium":[132],"14.4":[138],"ml/min/kg":[139,161],"0.12":[145],"h,":[146],"same":[148],"raised":[150],"ascites":[153],"decreased":[156],"0.092":[160],"increased":[164],"12":[168],"h.":[169],"100-fold":[171],"enhancement":[172],"hMAb's":[175],"was":[177],"not":[178],"affected":[179],"by":[180],"purification":[182],"process.":[183],"Some":[184],"potential":[185],"molecular":[186],"structures":[187],"involved":[188],"hMAb":[195],"are":[196],"discussed.":[197]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}